CCND1 and cancer: Besides, ISL1 was also verified to be a novel regulator of the cyclin D1 and c-Myc genes in cancer [15], and it could predict prognostics for cancers like gastric cancer, bladder cancer, and may also act as a biomarker in NB [13, 16–18].